Stock NGEN NERVGEN PHARMA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus NervGen Pharma Corp.

Equities

NGEN

CA64082X2032

Market Closed - Toronto S.E.
Other stock markets
 01:29:59 04/05/2024 am IST 		5-day change 1st Jan Change
2.33 CAD +7.87% Intraday chart for NervGen Pharma Corp. +10.43% -13.70%
17/04 NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update MT
17/04 NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on NervGen Pharma Corp.

Price target over the last 5 years

History of analyst recommendation changes

7b0d.45jFO-npmPGnqSAaK_Ja7KKxGYYa-yQALqW5Jm7rDYg.mfeoSaCtqsT9kVROT8Uzo_D8e8ssuE1xW-T_ZQWbYf-72oFvm7DSnO39Uw~ddd0573f1e43931bb56533bede22a9bd

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
2.33 CAD
Average target price
4.5 CAD
Spread / Average Target
+93.13%
High Price Target
5 CAD
Spread / Highest target
+114.59%
Low Price Target
4 CAD
Spread / Lowest Target
+71.67%

Consensus detail

Consensus revision (last 18 months)

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NGEN Stock
  4. Consensus NervGen Pharma Corp.